Drug lobby group starts ad campaign to defend pricing
Add BT as a preferred sourceSan Francisco
A TOP pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices.
"We're under pressure and scrutiny like never before," said Jim Greenwood, chief executive officer of the Biotechnology Innovation Organization (BIO). The campaign, called "Innovation Saves", says new drugs can save both lives and costs to the healthcare system. BIO is spending "low to mid-seven digits" on the ads, according to Mr Greenwood, or about US$1 million to US$5 million.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Not retirement, but a rewiring and fresh perspectives post-DBS, says Piyush Gupta
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
Should developers build more one-bedroom condo units?
